The use of amyloid imaging in clinical praxis: a critical review

Article OPEN
Nordberg, Agneta;
  • Related identifiers: doi: 10.1007/s40336-015-0100-8
  • Subject: Alzheimer’s disease | Amyloid imaging | 11C-Pittsburgh compound B | 18F-florbetapir | Clinical praxis | Mild cognitive impairment | PET
    mesheuropmc: mental disorders

Recent development in molecular imaging enables measurement of fibrillar amyloid plaque in Alzheimer (AD) brain using positron emission tomography (PET). Three tracers (florbetapir, flutemetamol, florbetaben) have been approved by FDA and EMA for use in clinical assessm... View more
Share - Bookmark

  • Download from
    ZENODO via ZENODO (Article, 2015)
  • Funded by
  • Cite this publication